The World Health Organization (WHO) has revised its priority lists for essential medicines, adding drugs for a variety of cancer types and for diabetes with associated comorbidities such as obesity.
The new additions to the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), which support global policy decisions around selection and universal coverage of medicines within all health systems, also now include treatments for cystic fibrosis, psoriasis and haemophilia.